SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Infinity Pharmaceuticals Q2 EPS $(0.16) Beats $(0.19) Estimate, Sales $360.00K Beat $160.00K Estimate

Infinity Pharmaceuticals (NASDAQ:INFI) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 11.11 percent increase over losses of $(0.18) per

Benzinga · -
Infinity Pharmaceuticals (NASDAQ: INFI) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 11.11 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $360.00 thousand which beat the analyst consensus estimate of $160.00 thousand by 125.00 percent. This is a 40.08 percent increase over sales of $257.00 thousand the same period last year.